These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31631785)

  • 1. GILT restricts the cellular entry mediated by the envelope glycoproteins of SARS-CoV, Ebola virus and Lassa fever virus.
    Chen D; Hou Z; Jiang D; Zheng M; Li G; Zhang Y; Li R; Lin H; Chang J; Zeng H; Guo JT; Zhao X
    Emerg Microbes Infect; 2019; 8(1):1511-1523. PubMed ID: 31631785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).
    Zhou N; Pan T; Zhang J; Li Q; Zhang X; Bai C; Huang F; Peng T; Zhang J; Liu C; Tao L; Zhang H
    J Biol Chem; 2016 Apr; 291(17):9218-32. PubMed ID: 26953343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses.
    Hulseberg CE; Fénéant L; Szymańska-de Wijs KM; Kessler NP; Nelson EA; Shoemaker CJ; Schmaljohn CS; Polyak SJ; White JM
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30700611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring Viral Entry in Real-Time Using a Luciferase Recombinant Vesicular Stomatitis Virus Producing SARS-CoV-2, EBOV, LASV, CHIKV, and VSV Glycoproteins.
    Lay Mendoza MF; Acciani MD; Levit CN; Santa Maria C; Brindley MA
    Viruses; 2020 Dec; 12(12):. PubMed ID: 33348746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ebola virus and severe acute respiratory syndrome coronavirus display late cell entry kinetics: evidence that transport to NPC1+ endolysosomes is a rate-defining step.
    Mingo RM; Simmons JA; Shoemaker CJ; Nelson EA; Schornberg KL; D'Souza RS; Casanova JE; White JM
    J Virol; 2015 Mar; 89(5):2931-43. PubMed ID: 25552710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging intracellular receptors for hemorrhagic fever viruses.
    Jae LT; Brummelkamp TR
    Trends Microbiol; 2015 Jul; 23(7):392-400. PubMed ID: 26004032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitors of signal peptide peptidase and subtilisin/kexin-isozyme 1 inhibit Ebola virus glycoprotein-driven cell entry by interfering with activity and cellular localization of endosomal cathepsins.
    Plegge T; Spiegel M; Krüger N; Nehlmeier I; Winkler M; González Hernández M; Pöhlmann S
    PLoS One; 2019; 14(4):e0214968. PubMed ID: 30973897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced methods for unbiased deep sequencing of Lassa and Ebola RNA viruses from clinical and biological samples.
    Matranga CB; Andersen KG; Winnicki S; Busby M; Gladden AD; Tewhey R; Stremlau M; Berlin A; Gire SK; England E; Moses LM; Mikkelsen TS; Odia I; Ehiane PE; Folarin O; Goba A; Kahn SH; Grant DS; Honko A; Hensley L; Happi C; Garry RF; Malboeuf CM; Birren BW; Gnirke A; Levin JZ; Sabeti PC
    Genome Biol; 2014; 15(11):519. PubMed ID: 25403361
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 25-Hydroxycholesterol Inhibition of Lassa Virus Infection through Aberrant GP1 Glycosylation.
    Shrivastava-Ranjan P; Bergeron É; Chakrabarti AK; Albariño CG; Flint M; Nichol ST; Spiropoulou CF
    mBio; 2016 Dec; 7(6):. PubMed ID: 27999160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Lassa virus and Ebola virus infection in host cells treated with the kinase inhibitors genistein and tyrphostin.
    Kolokoltsov AA; Adhikary S; Garver J; Johnson L; Davey RA; Vela EM
    Arch Virol; 2012 Jan; 157(1):121-7. PubMed ID: 21947546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunobiology of Ebola and Lassa virus infections.
    Prescott JB; Marzi A; Safronetz D; Robertson SJ; Feldmann H; Best SM
    Nat Rev Immunol; 2017 Mar; 17(3):195-207. PubMed ID: 28111475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cathepsins B and L activate Ebola but not Marburg virus glycoproteins for efficient entry into cell lines and macrophages independent of TMPRSS2 expression.
    Gnirss K; Kühl A; Karsten C; Glowacka I; Bertram S; Kaup F; Hofmann H; Pöhlmann S
    Virology; 2012 Mar; 424(1):3-10. PubMed ID: 22222211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexestrol, an estrogen receptor agonist, inhibits Lassa virus entry.
    Zhang Z; Takenaga T; Fehling SK; Igarashi M; Hirokawa T; Muramoto Y; Yamauchi K; Onishi C; Nakano M; Urata S; Groseth A; Strecker T; Noda T
    J Virol; 2024 Jul; 98(7):e0071424. PubMed ID: 38809021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a broad-spectrum antiviral small molecule against severe acute respiratory syndrome coronavirus and Ebola, Hendra, and Nipah viruses by using a novel high-throughput screening assay.
    Elshabrawy HA; Fan J; Haddad CS; Ratia K; Broder CC; Caffrey M; Prabhakar BS
    J Virol; 2014 Apr; 88(8):4353-65. PubMed ID: 24501399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Sequencing Uncovers Origins and Evolution of Lassa Virus.
    Andersen KG; Shapiro BJ; Matranga CB; Sealfon R; Lin AE; Moses LM; Folarin OA; Goba A; Odia I; Ehiane PE; Momoh M; England EM; Winnicki S; Branco LM; Gire SK; Phelan E; Tariyal R; Tewhey R; Omoniwa O; Fullah M; Fonnie R; Fonnie M; Kanneh L; Jalloh S; Gbakie M; Saffa S; Karbo K; Gladden AD; Qu J; Stremlau M; Nekoui M; Finucane HK; Tabrizi S; Vitti JJ; Birren B; Fitzgerald M; McCowan C; Ireland A; Berlin AM; Bochicchio J; Tazon-Vega B; Lennon NJ; Ryan EM; Bjornson Z; Milner DA; Lukens AK; Broodie N; Rowland M; Heinrich M; Akdag M; Schieffelin JS; Levy D; Akpan H; Bausch DG; Rubins K; McCormick JB; Lander ES; Günther S; Hensley L; Okogbenin S; ; Schaffner SF; Okokhere PO; Khan SH; Grant DS; Akpede GO; Asogun DA; Gnirke A; Levin JZ; Happi CT; Garry RF; Sabeti PC
    Cell; 2015 Aug; 162(4):738-50. PubMed ID: 26276630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus entry. Lassa virus entry requires a trigger-induced receptor switch.
    Jae LT; Raaben M; Herbert AS; Kuehne AI; Wirchnianski AS; Soh TK; Stubbs SH; Janssen H; Damme M; Saftig P; Whelan SP; Dye JM; Brummelkamp TR
    Science; 2014 Jun; 344(6191):1506-10. PubMed ID: 24970085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct Intracellular Visualization of Ebola Virus-Receptor Interaction by
    Mittler E; Alkutkar T; Jangra RK; Chandran K
    mBio; 2021 Jan; 12(1):. PubMed ID: 33436438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2.
    Zhao X; Zheng S; Chen D; Zheng M; Li X; Li G; Lin H; Chang J; Zeng H; Guo JT
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of residues in Lassa virus glycoprotein 1 involved in receptor switch.
    Guo J; Wan Y; Liu Y; Jia X; Dong S; Xiao G; Wang W
    Virol Sin; 2024 Aug; 39(4):600-608. PubMed ID: 38851430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.